XEROX HOLDINGS CORP (XRX) Fundamental Analysis & Valuation

NASDAQ:XRX • US98421M1062

Current stock price

1.22 USD
-0.06 (-4.69%)
At close:
1.26 USD
+0.04 (+3.28%)
After Hours:

This XRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. XRX Profitability Analysis

1.1 Basic Checks

  • XRX had negative earnings in the past year.
  • In the past year XRX had a positive cash flow from operations.
  • In the past 5 years XRX always reported negative net income.
  • Each year in the past 5 years XRX had a positive operating cash flow.
XRX Yearly Net Income VS EBIT VS OCF VS FCFXRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

  • XRX has a Return On Assets (-10.62%) which is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -158.51%, XRX is doing worse than 72.97% of the companies in the same industry.
Industry RankSector Rank
ROA -10.62%
ROE -158.51%
ROIC N/A
ROA(3y)-8.9%
ROA(5y)-6.63%
ROE(3y)-87.49%
ROE(5y)-56.4%
ROIC(3y)N/A
ROIC(5y)N/A
XRX Yearly ROA, ROE, ROICXRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • XRX has a Gross Margin of 27.07%. This is comparable to the rest of the industry: XRX outperforms 48.65% of its industry peers.
  • In the last couple of years the Gross Margin of XRX has declined.
  • XRX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.02%
GM growth 5Y-6.26%
XRX Yearly Profit, Operating, Gross MarginsXRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. XRX Health Analysis

2.1 Basic Checks

  • XRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • XRX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for XRX has been reduced compared to 5 years ago.
  • Compared to 1 year ago, XRX has a worse debt to assets ratio.
XRX Yearly Shares OutstandingXRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
XRX Yearly Total Debt VS Total AssetsXRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • XRX has an Altman-Z score of 1.09. This is a bad value and indicates that XRX is not financially healthy and even has some risk of bankruptcy.
  • XRX has a worse Altman-Z score (1.09) than 62.16% of its industry peers.
  • The Debt to FCF ratio of XRX is 31.93, which is on the high side as it means it would take XRX, 31.93 years of fcf income to pay off all of its debts.
  • XRX has a Debt to FCF ratio of 31.93. This is comparable to the rest of the industry: XRX outperforms 51.35% of its industry peers.
  • XRX has a Debt/Equity ratio of 6.10. This is a high value indicating a heavy dependency on external financing.
  • XRX's Debt to Equity ratio of 6.10 is on the low side compared to the rest of the industry. XRX is outperformed by 72.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.1
Debt/FCF 31.93
Altman-Z 1.09
ROIC/WACCN/A
WACC4.15%
XRX Yearly LT Debt VS Equity VS FCFXRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

2.3 Liquidity

  • A Current Ratio of 1.11 indicates that XRX should not have too much problems paying its short term obligations.
  • XRX has a Current ratio of 1.11. This is in the lower half of the industry: XRX underperforms 64.86% of its industry peers.
  • XRX has a Quick Ratio of 1.11. This is a bad value and indicates that XRX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Quick ratio of XRX (0.79) is worse than 62.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.79
XRX Yearly Current Assets VS Current LiabilitesXRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. XRX Growth Analysis

3.1 Past

  • XRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -162.50%.
  • The Revenue has grown by 12.88% in the past year. This is quite good.
EPS 1Y (TTM)-162.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.78%
Revenue 1Y (TTM)12.88%
Revenue growth 3Y-0.4%
Revenue growth 5Y0%
Sales Q2Q%25.73%

3.2 Future

  • XRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.51% yearly.
  • XRX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.51% yearly.
EPS Next Y177.55%
EPS Next 2Y98.66%
EPS Next 3Y55.51%
EPS Next 5YN/A
Revenue Next Year6.5%
Revenue Next 2Y2.6%
Revenue Next 3Y1.51%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XRX Yearly Revenue VS EstimatesXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
XRX Yearly EPS VS EstimatesXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. XRX Valuation Analysis

4.1 Price/Earnings Ratio

  • XRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 2.62, the valuation of XRX can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, XRX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • XRX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.54.
Industry RankSector Rank
PE N/A
Fwd PE 2.62
XRX Price Earnings VS Forward Price EarningsXRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, XRX is valued a bit cheaper than 72.97% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, XRX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.18
EV/EBITDA 14.69
XRX Per share dataXRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • XRX's earnings are expected to grow with 55.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y98.66%
EPS Next 3Y55.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. XRX Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 8.13%, XRX is a good candidate for dividend investing.
  • In the last 3 months the price of XRX has falen by -51.97%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • XRX's Dividend Yield is rather good when compared to the industry average which is at 0.75. XRX pays more dividend than 100.00% of the companies in the same industry.
  • XRX's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 8.13%

5.2 History

  • The dividend of XRX decreases each year by -12.86%.
  • XRX has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-12.86%
Div Incr Years0
Div Non Decr Years0
XRX Yearly Dividends per shareXRX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • XRX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-6.81%
EPS Next 2Y98.66%
EPS Next 3Y55.51%
XRX Yearly Income VS Free CF VS DividendXRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

More info and screens

Find the best dividend stocksShow peers with best dividend

XRX Fundamentals: All Metrics, Ratios and Statistics

XEROX HOLDINGS CORP

NASDAQ:XRX (4/10/2026, 8:00:30 PM)

After market: 1.26 +0.04 (+3.28%)

1.22

-0.06 (-4.69%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)01-29
Earnings (Next)04-28
Inst Owners82.29%
Inst Owner Change0.02%
Ins Owners1.34%
Ins Owner Change-1.05%
Market Cap156.92M
Revenue(TTM)7.02B
Net Income(TTM)-1.04B
Analysts46
Price Target2.3 (88.52%)
Short Float %22.93%
Short Ratio7.12
Dividend
Industry RankSector Rank
Dividend Yield 8.13%
Yearly Dividend0.56
Dividend Growth(5Y)-12.86%
DP-6.81%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-69.66%
Min EPS beat(2)-199.01%
Max EPS beat(2)59.69%
EPS beat(4)1
Avg EPS beat(4)-282.35%
Min EPS beat(4)-892.08%
Max EPS beat(4)59.69%
EPS beat(8)1
Avg EPS beat(8)-166.17%
EPS beat(12)4
Avg EPS beat(12)-91.07%
EPS beat(16)6
Avg EPS beat(16)-75.19%
Revenue beat(2)0
Avg Revenue beat(2)-4.64%
Min Revenue beat(2)-4.65%
Max Revenue beat(2)-4.62%
Revenue beat(4)1
Avg Revenue beat(4)-3%
Min Revenue beat(4)-4.65%
Max Revenue beat(4)0.96%
Revenue beat(8)2
Avg Revenue beat(8)-2.85%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)4
Avg Revenue beat(16)-2.06%
PT rev (1m)-28.95%
PT rev (3m)-69.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3663.62%
EPS NY rev (1m)0%
EPS NY rev (3m)-61.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.8%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.62
P/S 0.02
P/FCF 1.18
P/OCF 0.7
P/B 0.24
P/tB N/A
EV/EBITDA 14.69
EPS(TTM)-0.6
EYN/A
EPS(NY)0.47
Fwd EY38.14%
FCF(TTM)1.03
FCFY84.76%
OCF(TTM)1.74
OCFY142.75%
SpS54.59
BVpS5.12
TBVpS-19.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.62%
ROE -158.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.07%
FCFM 1.89%
ROA(3y)-8.9%
ROA(5y)-6.63%
ROE(3y)-87.49%
ROE(5y)-56.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.02%
GM growth 5Y-6.26%
F-Score3
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 6.1
Debt/FCF 31.93
Debt/EBITDA 15.15
Cap/Depr 27.49%
Cap/Sales 1.3%
Interest Coverage N/A
Cash Conversion 84.53%
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.79
Altman-Z 1.09
F-Score3
WACC4.15%
ROIC/WACCN/A
Cap/Depr(3y)19.43%
Cap/Depr(5y)20.04%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-162.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.78%
EPS Next Y177.55%
EPS Next 2Y98.66%
EPS Next 3Y55.51%
EPS Next 5YN/A
Revenue 1Y (TTM)12.88%
Revenue growth 3Y-0.4%
Revenue growth 5Y0%
Sales Q2Q%25.73%
Revenue Next Year6.5%
Revenue Next 2Y2.6%
Revenue Next 3Y1.51%
Revenue Next 5YN/A
EBIT growth 1Y-141.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year99.79%
EBIT Next 3Y38.48%
EBIT Next 5YN/A
FCF growth 1Y-71.52%
FCF growth 3Y9.25%
FCF growth 5Y-22.44%
OCF growth 1Y-56.16%
OCF growth 3Y12.1%
OCF growth 5Y-16.38%

XEROX HOLDINGS CORP / XRX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of XEROX HOLDINGS CORP (XRX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to XRX.


Can you provide the valuation status for XEROX HOLDINGS CORP?

ChartMill assigns a valuation rating of 6 / 10 to XEROX HOLDINGS CORP (XRX). This can be considered as Fairly Valued.


How profitable is XEROX HOLDINGS CORP (XRX) stock?

XEROX HOLDINGS CORP (XRX) has a profitability rating of 2 / 10.


Can you provide the dividend sustainability for XRX stock?

The dividend rating of XEROX HOLDINGS CORP (XRX) is 4 / 10 and the dividend payout ratio is -6.81%.